J Korean Ophthalmol Soc.  1995 Oct;36(10):1790-1797.

Clinical Evaluation of the Traumatic Optic Neuropathy

Affiliations
  • 1Department of Ophthalmology, Chonnam University, Medical School, Kwangju, Korea.
  • 2Department of Otolaryngology, Chonnam University, Medical School, Kwangju, Korea.

Abstract

The nineteen patients(20 eyes) of traumatic optic neuropathy were investigated to evaluate the effectiveness of high dose corticosteroid for the visual improvernent in the early treatment of this disease. The relationships between the affected region and visual improvement, the interval to treatment and final visual acuity, the initial visual acuity and final visual acuity were studied. 250mg of methylprednisolone was administered intravenously every 6 hours followed by tapering using oral prednisone. The optic canal decompression was performed in five patients suspected swelling of optic nerve or optic canal fracture revealed by orbital CT. It is difficult to know the relationships between the affected region and visual improvement, the interval to treatment and final visual acuity. The vision was improved in nine of eleven patients who had an initial visual acuity of above light perception, but in the two of nine patients who had an initial visual acuity of no light perception. The two of five patients treated with a combina tion of high dose corticosteroid and optic canal decompression showed improved visual function. In initial treatment of traumatic optic neuropathy, high dose corticosteroid was effective and combined optic canal decompression was helpful, if indicated.

Keyword

High dose corticosteroid; Optic canal decompression; Traumatic optic neuropathy

MeSH Terms

Decompression
Humans
Methylprednisolone
Optic Nerve
Optic Nerve Injuries*
Orbit
Prednisone
Visual Acuity
Methylprednisolone
Prednisone
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr